Coronavirus

Economy & Politics

Home
Economy & Politics
Coronavirus

COVID is evolving quickly in white-tailed deer, study finds

COVID is evolving quickly in white-tailed deer, study finds

New coronavirus variant has experts on alert and WHO is urging countries to step up COVID surveillance

WHO names Eris a coronavirus variant of interest. Here’s what you need to know.

New ‘Eris’ COVID variant is dominant in the U.S., but a shortage of data is making it hard to track

Update your iPhone: Apple just pushed out an important security update

‘She needs the money for care’: My 103-year-old grandmother’s adviser bought 5 bank stocks. She lost $300,000. Can I sue?

Here’s why Wall Street may be overreacting about Apple’s China’s challenges

Confused about how much to tip? Here is a detailed guide

Retire to Arizona? Seriously?

VinFast loses more than $140 billion in market cap in two weeks after week-long nosedive for EV maker

Nio, Alibaba stocks drop as part of broad selloff in the ADS of China-based companies

When a cardiologist invited his patients to walk with him in a local park, 100 people showed up. It was the beginning of a global program.

Cruise travel is back but economic uncertainty may cool future demand

I’m retiring at 65 with $2 million, an $850,000 home and $3,500 a month in Social Security. Should I follow the 4% rule if I don’t want to leave an inheritance?

Moderna says updated COVID vaccine effective against BA.2.86 Pirola variant

MRNA

0.10%

Sep. 6, 2023 at 8:12 a.m. ET by Eleanor Laise

Pfizer, BioNTech Get CHMP Backing for Omicron XBB.1.5-Adapted Covid-19 Vaccine

Aug. 30, 2023 at 10:36 a.m. ET

Pfizer, BioNTech updated COVID vaccine to treat new variants gets CHMP recommendation use in Europe

PFE

-0.26%

Aug. 30, 2023 at 10:15 a.m. ET by Tomi Kilgore

Coronavirus 5 Things to Know About the New ‘Pirola’ Variant of Covid

PFE

-0.26%

Aug. 29, 2023 at 3:03 p.m. ET by Barron's

Biotech and Pharma Covid-19 Hospitalizations Jump. So Could Vaccine Demand.

Aug. 22, 2023 at 4:46 p.m. ET by Barron's

Palo Alto Networks shares surge after earnings, Tesla climbs and more stocks on the move

-0.53%

Aug. 21, 2023 at 11:07 a.m. ET by MarketWatch

As COVID hospitalizations rise, Pfizer and Moderna say updated shots show promise against Eris variant

BNTX

-0.27%

Aug. 19, 2023 at 2:53 p.m. ET by Eleanor Laise

Biotech and Pharma Covid Vaccine Revenues Are Caving. New Boosters May Not Help.

NVAX

-6.06%

Aug. 11, 2023 at 9:09 a.m. ET by Barron's

BioNTech Swung to 2Q Loss on Inventory Write-Offs, But Continues to Expect Billions in Covid Shot Sales

Aug. 7, 2023 at 6:31 a.m. ET

Moderna Files Submission to Health Canada for Updated Covid-19 Vaccine

mdrthu

Jun. 29, 2023 at 2:13 p.m. ET

Markets The Market Thinks the Fed Is Wrong. Why That’s Dangerous.

Jun. 16, 2023 at 6:27 a.m. ET

FDA advisers endorse updating COVID vaccines to target latest omicron strain

MRNA

0.10%

Jun. 15, 2023 at 4:49 p.m. ET by Associated Press

Biotech and Pharma The FDA Is Prepping for Fall Covid Boosters. The Next Step Is Today.

mdrthu

Jun. 15, 2023 at 4:46 p.m. ET by Barron's

WHO advisory panel is recommending that future COVID vaccines be based on newer variant such as XBB.1

May. 18, 2023 at 12:26 p.m. ET by Ciara Linnane

As COVID public health emergency ends, ‘whack-a-mole’ virus won’t be easy to track

BNTX

-0.27%

May. 10, 2023 at 2:30 p.m. ET by Eleanor Laise

COVID is evolving quickly in white-tailed deer, study finds

COVID is evolving quickly in white-tailed deer, study finds

New coronavirus variant has experts on alert and WHO is urging countries to step up COVID surveillance

WHO names Eris a coronavirus variant of interest. Here’s what you need to know.

New ‘Eris’ COVID variant is dominant in the U.S., but a shortage of data is making it hard to track

Most Popular

Update your iPhone: Apple just pushed out an important security update

‘She needs the money for care’: My 103-year-old grandmother’s adviser bought 5 bank stocks. She lost $300,000. Can I sue?

Here’s why Wall Street may be overreacting about Apple’s China’s challenges

Confused about how much to tip? Here is a detailed guide

Retire to Arizona? Seriously?

VinFast loses more than $140 billion in market cap in two weeks after week-long nosedive for EV maker

Nio, Alibaba stocks drop as part of broad selloff in the ADS of China-based companies

When a cardiologist invited his patients to walk with him in a local park, 100 people showed up. It was the beginning of a global program.

Cruise travel is back but economic uncertainty may cool future demand

I’m retiring at 65 with $2 million, an $850,000 home and $3,500 a month in Social Security. Should I follow the 4% rule if I don’t want to leave an inheritance?

More news about the pandemic

Moderna says updated COVID vaccine effective against BA.2.86 Pirola variant

Pfizer, BioNTech Get CHMP Backing for Omicron XBB.1.5-Adapted Covid-19 Vaccine

Pfizer, BioNTech updated COVID vaccine to treat new variants gets CHMP recommendation use in Europe

Coronavirus 5 Things to Know About the New ‘Pirola’ Variant of Covid

Biotech and Pharma Covid-19 Hospitalizations Jump. So Could Vaccine Demand.

Palo Alto Networks shares surge after earnings, Tesla climbs and more stocks on the move

As COVID hospitalizations rise, Pfizer and Moderna say updated shots show promise against Eris variant

Biotech and Pharma Covid Vaccine Revenues Are Caving. New Boosters May Not Help.

BioNTech Swung to 2Q Loss on Inventory Write-Offs, But Continues to Expect Billions in Covid Shot Sales

Moderna Files Submission to Health Canada for Updated Covid-19 Vaccine

Markets The Market Thinks the Fed Is Wrong. Why That’s Dangerous.

FDA advisers endorse updating COVID vaccines to target latest omicron strain

Biotech and Pharma The FDA Is Prepping for Fall Covid Boosters. The Next Step Is Today.

WHO advisory panel is recommending that future COVID vaccines be based on newer variant such as XBB.1

As COVID public health emergency ends, ‘whack-a-mole’ virus won’t be easy to track

No Recent Tickers

Coronavirus 5 Things to Know About the New ‘Pirola’ Variant of Covid

Biotech and Pharma Covid-19 Hospitalizations Jump. So Could Vaccine Demand.

Biotech and Pharma Covid Vaccine Revenues Are Caving. New Boosters May Not Help.

Markets The Market Thinks the Fed Is Wrong. Why That’s Dangerous.

Biotech and Pharma The FDA Is Prepping for Fall Covid Boosters. The Next Step Is Today.

Symbols

Private Companies

No Recent Tickers

Authors

Sections

Columns